Previously mentioned presence of SGLT2 proteins in many neoplasm types [11,12,13] offers a potential therapeutic target for restricting metabolic fuel uptake by cancer cells and thereby negatively influencing their molecular mechanisms. The gene discussed is SLC5A2; the disease is neoplasm.